Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses

André Mercanzini, Sai T. Reddy, Diana Velluto, Philippe Colin, Anne Maillard, Jean Charles Bensadoun, Jeffrey A. Hubbell, Philippe Renaud

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Controlled release coatings were developed for neuroprostheses with the aim of combating the tissue reaction following implantation in the brain. The coatings consist of poly(propylene sulfide) drug-eluting nanoparticles embedded in a poly(ethylene oxide) matrix. The nanoparticles are loaded with dexamethasone, an anti-inflammatory drug known to have an effect on the cells activated during the damage caused by implantation. The nanoparticles are not affected by the coating process and the drug remains bioactive after it is released. The coating was applied to microfabricated cortical neuroprostheses consisting of platinum and polyimide. Coated drug-eluting devices were implanted in the cortex of rats. After implantation the matrix dissolves, exposing the electrode surfaces, while the nanoparticles remain in the vicinity of the tissue-implant interface. Using electrical impedance spectroscopy and comparative histology, a long-term decrease in the tissue response in comparison to control devices was observed. These coatings can therefore be used to increase the reliability and long-term efficacy of neuroprostheses.

Original languageEnglish
Pages (from-to)196-202
Number of pages7
JournalJournal of Controlled Release
Volume145
Issue number3
DOIs
StatePublished - Aug 1 2010
Externally publishedYes

Fingerprint

Nanoparticles
Pharmaceutical Preparations
Comparative Histology
Dielectric Spectroscopy
Ethylene Oxide
Equipment and Supplies
Platinum
Electric Impedance
Dexamethasone
Electrodes
Anti-Inflammatory Agents
Brain

Keywords

  • Microfabrication
  • Nanoparticles
  • Neuroprosthesis

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Mercanzini, A., Reddy, S. T., Velluto, D., Colin, P., Maillard, A., Bensadoun, J. C., ... Renaud, P. (2010). Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. Journal of Controlled Release, 145(3), 196-202. https://doi.org/10.1016/j.jconrel.2010.04.025

Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. / Mercanzini, André; Reddy, Sai T.; Velluto, Diana; Colin, Philippe; Maillard, Anne; Bensadoun, Jean Charles; Hubbell, Jeffrey A.; Renaud, Philippe.

In: Journal of Controlled Release, Vol. 145, No. 3, 01.08.2010, p. 196-202.

Research output: Contribution to journalArticle

Mercanzini, A, Reddy, ST, Velluto, D, Colin, P, Maillard, A, Bensadoun, JC, Hubbell, JA & Renaud, P 2010, 'Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses', Journal of Controlled Release, vol. 145, no. 3, pp. 196-202. https://doi.org/10.1016/j.jconrel.2010.04.025
Mercanzini, André ; Reddy, Sai T. ; Velluto, Diana ; Colin, Philippe ; Maillard, Anne ; Bensadoun, Jean Charles ; Hubbell, Jeffrey A. ; Renaud, Philippe. / Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. In: Journal of Controlled Release. 2010 ; Vol. 145, No. 3. pp. 196-202.
@article{14779ed0cc27471bae79b1d7e53ba38f,
title = "Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses",
abstract = "Controlled release coatings were developed for neuroprostheses with the aim of combating the tissue reaction following implantation in the brain. The coatings consist of poly(propylene sulfide) drug-eluting nanoparticles embedded in a poly(ethylene oxide) matrix. The nanoparticles are loaded with dexamethasone, an anti-inflammatory drug known to have an effect on the cells activated during the damage caused by implantation. The nanoparticles are not affected by the coating process and the drug remains bioactive after it is released. The coating was applied to microfabricated cortical neuroprostheses consisting of platinum and polyimide. Coated drug-eluting devices were implanted in the cortex of rats. After implantation the matrix dissolves, exposing the electrode surfaces, while the nanoparticles remain in the vicinity of the tissue-implant interface. Using electrical impedance spectroscopy and comparative histology, a long-term decrease in the tissue response in comparison to control devices was observed. These coatings can therefore be used to increase the reliability and long-term efficacy of neuroprostheses.",
keywords = "Microfabrication, Nanoparticles, Neuroprosthesis",
author = "Andr{\'e} Mercanzini and Reddy, {Sai T.} and Diana Velluto and Philippe Colin and Anne Maillard and Bensadoun, {Jean Charles} and Hubbell, {Jeffrey A.} and Philippe Renaud",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.jconrel.2010.04.025",
language = "English",
volume = "145",
pages = "196--202",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses

AU - Mercanzini, André

AU - Reddy, Sai T.

AU - Velluto, Diana

AU - Colin, Philippe

AU - Maillard, Anne

AU - Bensadoun, Jean Charles

AU - Hubbell, Jeffrey A.

AU - Renaud, Philippe

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Controlled release coatings were developed for neuroprostheses with the aim of combating the tissue reaction following implantation in the brain. The coatings consist of poly(propylene sulfide) drug-eluting nanoparticles embedded in a poly(ethylene oxide) matrix. The nanoparticles are loaded with dexamethasone, an anti-inflammatory drug known to have an effect on the cells activated during the damage caused by implantation. The nanoparticles are not affected by the coating process and the drug remains bioactive after it is released. The coating was applied to microfabricated cortical neuroprostheses consisting of platinum and polyimide. Coated drug-eluting devices were implanted in the cortex of rats. After implantation the matrix dissolves, exposing the electrode surfaces, while the nanoparticles remain in the vicinity of the tissue-implant interface. Using electrical impedance spectroscopy and comparative histology, a long-term decrease in the tissue response in comparison to control devices was observed. These coatings can therefore be used to increase the reliability and long-term efficacy of neuroprostheses.

AB - Controlled release coatings were developed for neuroprostheses with the aim of combating the tissue reaction following implantation in the brain. The coatings consist of poly(propylene sulfide) drug-eluting nanoparticles embedded in a poly(ethylene oxide) matrix. The nanoparticles are loaded with dexamethasone, an anti-inflammatory drug known to have an effect on the cells activated during the damage caused by implantation. The nanoparticles are not affected by the coating process and the drug remains bioactive after it is released. The coating was applied to microfabricated cortical neuroprostheses consisting of platinum and polyimide. Coated drug-eluting devices were implanted in the cortex of rats. After implantation the matrix dissolves, exposing the electrode surfaces, while the nanoparticles remain in the vicinity of the tissue-implant interface. Using electrical impedance spectroscopy and comparative histology, a long-term decrease in the tissue response in comparison to control devices was observed. These coatings can therefore be used to increase the reliability and long-term efficacy of neuroprostheses.

KW - Microfabrication

KW - Nanoparticles

KW - Neuroprosthesis

UR - http://www.scopus.com/inward/record.url?scp=77954316270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954316270&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2010.04.025

DO - 10.1016/j.jconrel.2010.04.025

M3 - Article

C2 - 20447428

AN - SCOPUS:77954316270

VL - 145

SP - 196

EP - 202

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -